A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient's Awareness

Arunachalam M Anusa1, Rooban Thavarajah2,3, Dinesh Nayak4

  • 1Department of Psychiatry, Affiliated to Sri Balaji Vidyapeeth, Shri Sathya Sai Medical College and Research Institute, Kanchipuram.

Abstract

Insights

Schizophrenia patients on antipsychotics risk tardive dyskinesia (TD). This study links TD orofacial movements to patient stress, aiding dental care for those with TD.

Area of Science:

  • Psychiatry
  • Neurology
  • Dentistry

Background:

  • Schizophrenia requires long-term antipsychotic treatment.
  • Long-term antipsychotic use can lead to tardive dyskinesia (TD), a movement disorder.
  • Abnormal Involuntary Movement Scale (AIMS) measures TD severity.

Purpose of the Study:

  • Examine the relationship between TD, orofacial muscle activity, and patient awareness of involuntary movements.
  • Inform dentists on providing oral care for schizophrenic patients with TD.
  • Highlight the need for physician and dentist awareness of TD for patient management.

Main Methods:

  • Analyzed data from 317 patients, with 38.3% showing AIM scores from 2 to 15.
  • Utilized descriptive and inferential statistical analysis (SPSS) with P≤0.05 significance.
  • Assessed orofacial features, drug history, and AIMS details.

Main Results:

  • Mean orofacial feature score was 3.43 ± 2.68 (n=56).
  • Tongue (67.54%), jaw (45.61%), and lip/perioral area (23.68%) were most affected orofacial muscles.
  • Patient perception of stress related to AIMs in jaw, tongue, limbs, and trunk was significant (P≤0.05).

Conclusions:

  • Approximately 1% of the global population with schizophrenia are at risk of developing TD.
  • Patients with TD may require specialized orodental care, including prosthodontic and restorative services.
  • Physicians and dentists must be aware of TD and its mechanisms for effective patient care.